GlassScriptPhysician profile
James P Sur
NPI 1447450788
$31,202.62
in general payments reported to CMS, 2019-2025
45 companies · $1,914 in 2025
The $1,914 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $1,934 · 2021: $6,472 · 2022: $1,765 · 2023: $2,055 · 2024: $2,125 · 2025: $1,914.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,434 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,433.77 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $660.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $21,112.02 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $1,245.78 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $1,104.40 | 2019-2025 | Camzyos, Eliquis |
| Actelion Pharmaceuticals US, INC. | $788.87 | 2019-2025 | Opsumit, Uptravi |
| Pfizer INC. | $719.86 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $643.55 | 2019-2022 | |
| Esperion Therapeutics, INC. | $525.64 | 2021-2025 | Nexletol |
| Endotronix, INC. | $434.73 | 2021-2025 | Cordella Pulomonary Artery Pressure Sensor |
| Cleerly, INC. | $412.13 | 2024-2025 | Cleerly Ischemia, Cleerly Labs |
| Astrazeneca Pharmaceuticals LP | $385.41 | 2019-2025 | Farxiga, Andexxa, Wainua |
| Merck Sharp & Dohme LLC | $369.31 | 2021-2025 | Verquvo, Winrevair |
| Amgen INC. | $321.63 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $312.70 | 2021-2025 | Watchman Flx, Watchman Access System, General - Balloon Catheters |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $259.50 | 2019-2025 | Lifevest |
| Cardiovascular Systems INC. | $232.77 | 2019-2023 | Diamondback Coronary |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| United Therapeutics Corporation | $214.24 | 2019 | |
| W. L. Gore & Associates, INC. | $195.11 | 2019-2024 | Gore Tag Thoracic Branch Endoprosthesis |
| Chiesi USA, INC. | $189.13 | 2019-2021 | |
| Cathworks, INC. | $146.32 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $140.78 | 2019-2024 | Jardiance |
| Shockwave Medical, INC | $138.65 | 2021 | |
| Atricure, INC. | $127.74 | 2024 | |
| Medtronic, INC. | $126.99 | 2021-2025 | Hawkone, Endurant Iis |
| Lexicon Pharmaceuticals, INC. | $117.90 | 2024 | Inpefa |
| Abiomed | $108.94 | 2019 | |
| Alnylam Pharmaceuticals INC. | $87.01 | 2021-2025 | Onpattro, Amvuttra |
| Terumo Medical Corporation | $78.12 | 2021-2023 | Metacross Otw, Tr Band, Azur Cx Detachable |
| Kestra Medical Technology Services, INC. | $76.05 | 2022-2023 | Assure Wcd |
| Sanofi-Aventis U.S. LLC | $67.12 | 2019 | |
| Abbott Laboratories | $67.10 | 2023-2025 | Cardiomems, Xact |
| Bard Peripheral Vascular, INC. | $59.63 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $51.26 | 2019-2024 | Evkeeza, Praluent |
| Novo Nordisk INC | $44.69 | 2022-2023 | Ozempic, Rybelsus |
| Lundbeck LLC | $44.15 | 2019 | |
| Daiichi Sankyo INC. | $40.64 | 2023 | Injectafer |
| Siemens Medical Solutions USA, INC. | $26.95 | 2025 | |
| Amarin Pharma, INC. | $26.28 | 2019 | |
| Gilead Sciences, INC. | $25.59 | 2019 | |
| Johnson & Johnson Health Care Systems INC. | $25.28 | 2022 | |
| Inspire Medical Systems, INC. | $22.09 | 2023 | Inspire |
| Cvrx, INC. | $20.14 | 2024 | Barostim Neo System |
| Philips North America LLC | $19.85 | 2022 | |
| Elutia, INC. | $18.92 | 2022 | |
| Teleflex LLC | $15.13 | 2025 | Guardian |
| Kowa Pharmaceuticals America, INC. | $12.52 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Sur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.